Undeterred By Randomized Trial Results, AUA Calls For Baseline PSA At Age 40.
Obama Reiterates Support For Doubling Budgets For Cancer Research, Other Science Agencies
Provenge Met Criteria For Approval, Sponsor Says
Senate Confirms Kansas Gov. Sebelius For HHS Secretary
Stronger Measures Needed To Reduce Conflict of Interest, IOM Report Says
NIH Releases Digestive Diseases Research Plan
Trending Stories
- Maura Gillison, who identified the role of HPV in head and neck cancer, changing the standard of care, dies at 61
- Prediction markets now allow betting on clinical trial results, FDA decisions
It’s a high-risk bet: Insider trading, equipoise, integrity of research, public trust are at stake - Trump plans a 200% tariff on imported generic drugs by 2029, raising fears of cancer drug shortages
“There is a reason why generics have been exempt from all the tariffs until now,” Brookings economist warns - Is it time to re-assess the practice and practicality of screening colonoscopy?
Modeling data, ACS guideline support greater use of noninvasive tests to ease system strain, help save lives - Retraction is not refutation: Why chrono-immunotherapy still deserves scientific investigation
- FDA’s OCE publishes three final guidances to increase clinical trial enrollment









